Virtual Reality Reward Training for Anhedonia: A Pilot Study.

anhedonia depression emotion positive affect treatment virtual reality

Journal

Frontiers in psychology
ISSN: 1664-1078
Titre abrégé: Front Psychol
Pays: Switzerland
ID NLM: 101550902

Informations de publication

Date de publication:
2020
Historique:
received: 02 10 2020
accepted: 04 12 2020
entrez: 25 1 2021
pubmed: 26 1 2021
medline: 26 1 2021
Statut: epublish

Résumé

Anhedonia is a risk factor for suicide and poor treatment response in depressed individuals. Most evidence-based psychological therapies target symptoms of heightened negative affect (e.g., negative inferential style) instead of deficits in positive affect (e.g., attenuated reward response) and typically show little benefit for anhedonia. Viewing positive scenes through virtual reality (VR) has been shown to increase positive affect and holds great promise for addressing anhedonic symptoms. In this pilot study, six participants with clinically significant depression completed 13 sessions of exposure to positive scenes in a controlled VR environment. Significant decreases were found in self-reported anhedonia, depression, anxiety, and impairments in functioning from baseline to 1-month follow-up. Negative affect decreased over all 13 sessions, and positive affect increased over sessions 8-13. Results suggest that positive experiences in VR may be a novel avenue for the treatment of anhedonia in depressed individuals.

Identifiants

pubmed: 33488482
doi: 10.3389/fpsyg.2020.613617
pmc: PMC7817899
doi:

Types de publication

Journal Article

Langues

eng

Pagination

613617

Informations de copyright

Copyright © 2021 Chen, Barnes-Horowitz, Treanor, Sun, Young and Craske.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Clin Psychol Rev. 2010 Nov;30(7):839-48
pubmed: 19939530
J Trauma Stress. 2008 Apr;21(2):209-13
pubmed: 18404648
Arch Gen Psychiatry. 2012 Nov;69(11):1104-12
pubmed: 23117634
Depress Anxiety. 2016 Oct;33(10):927-938
pubmed: 27699943
J Abnorm Psychol. 1995 Feb;104(1):3-14
pubmed: 7897050
Cogn Emot. 2011 Sep;25(6):1087-103
pubmed: 21895571
Am J Psychiatry. 2014 Feb;171(2):187-94
pubmed: 23929270
Behav Res Ther. 2019 Jul;118:130-140
pubmed: 31075675
J Abnorm Psychol. 1998 May;107(2):179-92
pubmed: 9604548
Front Psychol. 2019 Jan 28;10:55
pubmed: 30745888
Biometrics. 1997 Sep;53(3):983-97
pubmed: 9333350
Cogn Process. 2019 Aug;20(3):291-298
pubmed: 30569268
Clin J Pain. 2015 Jun;31(6):564-72
pubmed: 25551475
Cognit Ther Res. 2017;41(3):369-380
pubmed: 28515538
Drug Alcohol Depend. 2016 Apr 1;161:238-46
pubmed: 26944468
Biol Psychiatry. 2010 Mar 1;67(5):439-45
pubmed: 20034615
Br J Clin Psychol. 2009 Sep;48(Pt 3):255-73
pubmed: 19187578
Emotion. 2008 Jun;8(3):395-409
pubmed: 18540755
Aerosp Med Hum Perform. 2017 Jun 1;88(6):520-526
pubmed: 28539139
Br J Clin Psychol. 2004 Sep;43(Pt 3):245-65
pubmed: 15333231
Psychol Bull. 2016 Jan;142(1):18-78
pubmed: 26619211
J Pers Soc Psychol. 1988 Jun;54(6):1063-70
pubmed: 3397865
Annu Rev Clin Psychol. 2016;12:249-80
pubmed: 26772205
Clin Psychol Rev. 2007 Apr;27(3):348-65
pubmed: 17222490
Clin Psychol Psychother. 2012 Jul-Aug;19(4):326-40
pubmed: 22674611
Depress Anxiety. 2017 Mar;34(3):267-280
pubmed: 28060463
Emotion. 2019 Mar;19(2):292-300
pubmed: 29672074
Psychol Bull. 2007 Jan;133(1):122-48
pubmed: 17201573
Behav Res Ther. 2019 May;116:36-51
pubmed: 30776658
Int Clin Psychopharmacol. 1996 Jun;11 Suppl 3:89-95
pubmed: 8923116
Behav Ther. 2016 Sep;47(5):600-621
pubmed: 27816074
Behav Res Ther. 2013 Oct;51(10):623-32
pubmed: 23916631
Psychiatr Serv. 2008 Apr;59(4):361-8
pubmed: 18378832
Int J Psychiatry Med. 1997;27(2):93-105
pubmed: 9565717
Front Behav Neurosci. 2015 Mar 11;9:49
pubmed: 25814941
Am J Psychiatry. 1990 Sep;147(9):1189-94
pubmed: 2104515
J Consult Clin Psychol. 2019 May;87(5):457-471
pubmed: 30998048
Exp Brain Res. 2017 Mar;235(3):889-901
pubmed: 27915367
Psychiatry Res. 2009 Jan 30;165(1-2):163-74
pubmed: 19042030
Behav Res Ther. 2006 Jun;44(6):765-84
pubmed: 16620779

Auteurs

Kelly Chen (K)

Department of Psychology, University of Arizona, Tucson, AZ, United States.

Nora Barnes-Horowitz (N)

Department of Psychology, University of California, Los Angeles, Los Angeles, CA, United States.

Michael Treanor (M)

Department of Psychiatry, University of California, Los Angeles, Los Angeles, CA, United States.

Michael Sun (M)

Department of Psychology, Dartmouth College, Hanover, NH, United States.

Katherine S Young (KS)

Social, Genetic and Developmental Psychiatry Centre, King's College London, London, United Kingdom.

Michelle G Craske (MG)

Department of Psychology, University of California, Los Angeles, Los Angeles, CA, United States.
Department of Psychiatry, University of California, Los Angeles, Los Angeles, CA, United States.

Classifications MeSH